nodes	percent_of_prediction	percent_of_DWPC	metapath
Pralatrexate—FPGS—islet of Langerhans—type 2 diabetes mellitus	0.00884	0.0989	CbGeAlD
Pralatrexate—SLC19A1—adipose tissue—type 2 diabetes mellitus	0.00846	0.0947	CbGeAlD
Pralatrexate—FPGS—retina—type 2 diabetes mellitus	0.00755	0.0846	CbGeAlD
Pralatrexate—FPGS—cortex of kidney—type 2 diabetes mellitus	0.00609	0.0682	CbGeAlD
Pralatrexate—SLC19A1—liver—type 2 diabetes mellitus	0.00593	0.0664	CbGeAlD
Pralatrexate—FPGS—adipose tissue—type 2 diabetes mellitus	0.00564	0.0631	CbGeAlD
Pralatrexate—Tetrahydrofolic acid—MTR—type 2 diabetes mellitus	0.00492	0.316	CrCbGaD
Pralatrexate—DHFR—retina—type 2 diabetes mellitus	0.00491	0.0549	CbGeAlD
Pralatrexate—TYMS—Bortezomib—Nateglinide—type 2 diabetes mellitus	0.00474	1	CbGdCrCtD
Pralatrexate—TYMS—nephron tubule—type 2 diabetes mellitus	0.00467	0.0522	CbGeAlD
Pralatrexate—DHFR—nephron tubule—type 2 diabetes mellitus	0.00462	0.0517	CbGeAlD
Pralatrexate—DHFR—cardiovascular system—type 2 diabetes mellitus	0.00415	0.0465	CbGeAlD
Pralatrexate—DHFR—kidney—type 2 diabetes mellitus	0.00406	0.0455	CbGeAlD
Pralatrexate—TYMS—cortex of kidney—type 2 diabetes mellitus	0.00399	0.0447	CbGeAlD
Pralatrexate—DHFR—cortex of kidney—type 2 diabetes mellitus	0.00395	0.0443	CbGeAlD
Pralatrexate—FPGS—liver—type 2 diabetes mellitus	0.00395	0.0442	CbGeAlD
Pralatrexate—TYMS—adipose tissue—type 2 diabetes mellitus	0.0037	0.0414	CbGeAlD
Pralatrexate—DHFR—adipose tissue—type 2 diabetes mellitus	0.00366	0.041	CbGeAlD
Pralatrexate—TYMS—liver—type 2 diabetes mellitus	0.00259	0.029	CbGeAlD
Pralatrexate—DHFR—liver—type 2 diabetes mellitus	0.00257	0.0287	CbGeAlD
Pralatrexate—Leucovorin—ABCC2—type 2 diabetes mellitus	0.00226	0.145	CrCbGaD
Pralatrexate—Folic Acid—MTHFR—type 2 diabetes mellitus	0.00168	0.108	CrCbGaD
Pralatrexate—Tetrahydrofolic acid—MTHFR—type 2 diabetes mellitus	0.00168	0.108	CrCbGaD
Pralatrexate—Oedema—Pioglitazone—type 2 diabetes mellitus	0.00147	0.00311	CcSEcCtD
Pralatrexate—Abdominal pain—Repaglinide—type 2 diabetes mellitus	0.00147	0.0031	CcSEcCtD
Pralatrexate—Diarrhoea—Nateglinide—type 2 diabetes mellitus	0.00147	0.0031	CcSEcCtD
Pralatrexate—Anorexia—Glipizide—type 2 diabetes mellitus	0.00146	0.00309	CcSEcCtD
Pralatrexate—Neutropenia—Metformin—type 2 diabetes mellitus	0.00146	0.00308	CcSEcCtD
Pralatrexate—Rash—Chlorpropamide—type 2 diabetes mellitus	0.00146	0.00308	CcSEcCtD
Pralatrexate—Rash—Tolazamide—type 2 diabetes mellitus	0.00146	0.00308	CcSEcCtD
Pralatrexate—Tetrahydrofolic acid—ABCC2—type 2 diabetes mellitus	0.00146	0.0937	CrCbGaD
Pralatrexate—Upper respiratory tract infection—Metformin—type 2 diabetes mellitus	0.00145	0.00306	CcSEcCtD
Pralatrexate—Toxic epidermal necrolysis—Losartan—type 2 diabetes mellitus	0.00144	0.00305	CcSEcCtD
Pralatrexate—Rash—Linagliptin—type 2 diabetes mellitus	0.00144	0.00305	CcSEcCtD
Pralatrexate—Dermatitis—Linagliptin—type 2 diabetes mellitus	0.00144	0.00305	CcSEcCtD
Pralatrexate—Epistaxis—Valsartan—type 2 diabetes mellitus	0.00144	0.00304	CcSEcCtD
Pralatrexate—Vomiting—Acarbose—type 2 diabetes mellitus	0.00141	0.00298	CcSEcCtD
Pralatrexate—Thrombocytopenia—Glimepiride—type 2 diabetes mellitus	0.0014	0.00296	CcSEcCtD
Pralatrexate—Rash—Acarbose—type 2 diabetes mellitus	0.0014	0.00296	CcSEcCtD
Pralatrexate—Dermatitis—Acarbose—type 2 diabetes mellitus	0.0014	0.00296	CcSEcCtD
Pralatrexate—Tachycardia—Glimepiride—type 2 diabetes mellitus	0.0014	0.00295	CcSEcCtD
Pralatrexate—Neutropenia—Irbesartan—type 2 diabetes mellitus	0.00138	0.00291	CcSEcCtD
Pralatrexate—Nausea—Tolazamide—type 2 diabetes mellitus	0.00137	0.0029	CcSEcCtD
Pralatrexate—Nausea—Chlorpropamide—type 2 diabetes mellitus	0.00137	0.0029	CcSEcCtD
Pralatrexate—Upper respiratory tract infection—Irbesartan—type 2 diabetes mellitus	0.00137	0.00289	CcSEcCtD
Pralatrexate—Dyspnoea—Glipizide—type 2 diabetes mellitus	0.00137	0.00289	CcSEcCtD
Pralatrexate—Anorexia—Glimepiride—type 2 diabetes mellitus	0.00136	0.00288	CcSEcCtD
Pralatrexate—Vomiting—Nateglinide—type 2 diabetes mellitus	0.00136	0.00288	CcSEcCtD
Pralatrexate—Rash—Nateglinide—type 2 diabetes mellitus	0.00135	0.00285	CcSEcCtD
Pralatrexate—Dermatitis—Nateglinide—type 2 diabetes mellitus	0.00135	0.00285	CcSEcCtD
Pralatrexate—Anaemia—Glyburide—type 2 diabetes mellitus	0.00134	0.00283	CcSEcCtD
Pralatrexate—Decreased appetite—Glipizide—type 2 diabetes mellitus	0.00133	0.00282	CcSEcCtD
Pralatrexate—Nausea—Acarbose—type 2 diabetes mellitus	0.00132	0.00279	CcSEcCtD
Pralatrexate—Constipation—Glipizide—type 2 diabetes mellitus	0.00131	0.00277	CcSEcCtD
Pralatrexate—Pruritus—Repaglinide—type 2 diabetes mellitus	0.00131	0.00277	CcSEcCtD
Pralatrexate—Dyspnoea—Pioglitazone—type 2 diabetes mellitus	0.00131	0.00277	CcSEcCtD
Pralatrexate—Leukopenia—Glyburide—type 2 diabetes mellitus	0.00129	0.00274	CcSEcCtD
Pralatrexate—Oedema—Bromocriptine—type 2 diabetes mellitus	0.00129	0.00273	CcSEcCtD
Pralatrexate—Upper respiratory tract infection—Losartan—type 2 diabetes mellitus	0.00129	0.00272	CcSEcCtD
Pralatrexate—Dyspnoea—Glimepiride—type 2 diabetes mellitus	0.00128	0.0027	CcSEcCtD
Pralatrexate—Nausea—Nateglinide—type 2 diabetes mellitus	0.00127	0.00269	CcSEcCtD
Pralatrexate—Liver function test abnormal—Ramipril—type 2 diabetes mellitus	0.00127	0.00268	CcSEcCtD
Pralatrexate—Diarrhoea—Repaglinide—type 2 diabetes mellitus	0.00127	0.00268	CcSEcCtD
Pralatrexate—Fatigue—Pioglitazone—type 2 diabetes mellitus	0.00127	0.00268	CcSEcCtD
Pralatrexate—Tachycardia—Bromocriptine—type 2 diabetes mellitus	0.00126	0.00266	CcSEcCtD
Pralatrexate—Asthenia—Rosiglitazone—type 2 diabetes mellitus	0.00126	0.00266	CcSEcCtD
Pralatrexate—Back pain—Gliclazide—type 2 diabetes mellitus	0.00126	0.00266	CcSEcCtD
Pralatrexate—Gastrointestinal pain—Glipizide—type 2 diabetes mellitus	0.00125	0.00265	CcSEcCtD
Pralatrexate—Decreased appetite—Glimepiride—type 2 diabetes mellitus	0.00124	0.00263	CcSEcCtD
Pralatrexate—Decreased appetite—Sitagliptin—type 2 diabetes mellitus	0.00124	0.00262	CcSEcCtD
Pralatrexate—Pruritus—Rosiglitazone—type 2 diabetes mellitus	0.00124	0.00262	CcSEcCtD
Pralatrexate—Epistaxis—Irbesartan—type 2 diabetes mellitus	0.00124	0.00262	CcSEcCtD
Pralatrexate—Toxic epidermal necrolysis—Ramipril—type 2 diabetes mellitus	0.00124	0.00262	CcSEcCtD
Pralatrexate—Fatigue—Glimepiride—type 2 diabetes mellitus	0.00123	0.00261	CcSEcCtD
Pralatrexate—Anorexia—Bromocriptine—type 2 diabetes mellitus	0.00123	0.0026	CcSEcCtD
Pralatrexate—Fatigue—Sitagliptin—type 2 diabetes mellitus	0.00123	0.0026	CcSEcCtD
Pralatrexate—Constipation—Sitagliptin—type 2 diabetes mellitus	0.00122	0.00258	CcSEcCtD
Pralatrexate—Abdominal pain—Glipizide—type 2 diabetes mellitus	0.00121	0.00256	CcSEcCtD
Pralatrexate—Anaemia—Gliclazide—type 2 diabetes mellitus	0.0012	0.00254	CcSEcCtD
Pralatrexate—Diarrhoea—Rosiglitazone—type 2 diabetes mellitus	0.0012	0.00253	CcSEcCtD
Pralatrexate—Oedema—Glyburide—type 2 diabetes mellitus	0.00118	0.00249	CcSEcCtD
Pralatrexate—Vomiting—Repaglinide—type 2 diabetes mellitus	0.00118	0.00249	CcSEcCtD
Pralatrexate—Gastrointestinal pain—Glimepiride—type 2 diabetes mellitus	0.00117	0.00247	CcSEcCtD
Pralatrexate—Rash—Repaglinide—type 2 diabetes mellitus	0.00117	0.00247	CcSEcCtD
Pralatrexate—Dermatitis—Repaglinide—type 2 diabetes mellitus	0.00117	0.00247	CcSEcCtD
Pralatrexate—Gastrointestinal pain—Sitagliptin—type 2 diabetes mellitus	0.00117	0.00247	CcSEcCtD
Pralatrexate—Epistaxis—Losartan—type 2 diabetes mellitus	0.00116	0.00246	CcSEcCtD
Pralatrexate—Leukopenia—Gliclazide—type 2 diabetes mellitus	0.00116	0.00246	CcSEcCtD
Pralatrexate—Thrombocytopenia—Glyburide—type 2 diabetes mellitus	0.00116	0.00244	CcSEcCtD
Pralatrexate—Back pain—Valsartan—type 2 diabetes mellitus	0.00115	0.00244	CcSEcCtD
Pralatrexate—Dyspnoea—Bromocriptine—type 2 diabetes mellitus	0.00115	0.00243	CcSEcCtD
Pralatrexate—Methotrexate—MTHFR—type 2 diabetes mellitus	0.00115	0.074	CrCbGaD
Pralatrexate—Back pain—Orlistat—type 2 diabetes mellitus	0.00114	0.00241	CcSEcCtD
Pralatrexate—Cough—Gliclazide—type 2 diabetes mellitus	0.00113	0.0024	CcSEcCtD
Pralatrexate—Abdominal pain—Glimepiride—type 2 diabetes mellitus	0.00113	0.00239	CcSEcCtD
Pralatrexate—Abdominal pain—Sitagliptin—type 2 diabetes mellitus	0.00113	0.00238	CcSEcCtD
Pralatrexate—Pancytopenia—Ramipril—type 2 diabetes mellitus	0.00113	0.00238	CcSEcCtD
Pralatrexate—Anorexia—Glyburide—type 2 diabetes mellitus	0.00113	0.00238	CcSEcCtD
Pralatrexate—Decreased appetite—Bromocriptine—type 2 diabetes mellitus	0.00112	0.00237	CcSEcCtD
Pralatrexate—Fatigue—Bromocriptine—type 2 diabetes mellitus	0.00111	0.00235	CcSEcCtD
Pralatrexate—Neutropenia—Ramipril—type 2 diabetes mellitus	0.00111	0.00235	CcSEcCtD
Pralatrexate—Rash—Rosiglitazone—type 2 diabetes mellitus	0.0011	0.00233	CcSEcCtD
Pralatrexate—Constipation—Bromocriptine—type 2 diabetes mellitus	0.0011	0.00233	CcSEcCtD
Pralatrexate—Upper respiratory tract infection—Ramipril—type 2 diabetes mellitus	0.0011	0.00233	CcSEcCtD
Pralatrexate—Dermatitis—Rosiglitazone—type 2 diabetes mellitus	0.0011	0.00233	CcSEcCtD
Pralatrexate—Nausea—Repaglinide—type 2 diabetes mellitus	0.0011	0.00233	CcSEcCtD
Pralatrexate—Asthenia—Glipizide—type 2 diabetes mellitus	0.0011	0.00233	CcSEcCtD
Pralatrexate—Pruritus—Glipizide—type 2 diabetes mellitus	0.00109	0.00229	CcSEcCtD
Pralatrexate—Gastrointestinal pain—Bromocriptine—type 2 diabetes mellitus	0.00106	0.00223	CcSEcCtD
Pralatrexate—Asthenia—Pioglitazone—type 2 diabetes mellitus	0.00105	0.00223	CcSEcCtD
Pralatrexate—Dyspnoea—Glyburide—type 2 diabetes mellitus	0.00105	0.00222	CcSEcCtD
Pralatrexate—Diarrhoea—Glipizide—type 2 diabetes mellitus	0.00105	0.00222	CcSEcCtD
Pralatrexate—Cough—Valsartan—type 2 diabetes mellitus	0.00104	0.0022	CcSEcCtD
Pralatrexate—Nausea—Rosiglitazone—type 2 diabetes mellitus	0.00104	0.0022	CcSEcCtD
Pralatrexate—Thrombocytopenia—Gliclazide—type 2 diabetes mellitus	0.00104	0.00219	CcSEcCtD
Pralatrexate—Tachycardia—Gliclazide—type 2 diabetes mellitus	0.00103	0.00219	CcSEcCtD
Pralatrexate—Cough—Orlistat—type 2 diabetes mellitus	0.00103	0.00217	CcSEcCtD
Pralatrexate—Asthenia—Glimepiride—type 2 diabetes mellitus	0.00103	0.00217	CcSEcCtD
Pralatrexate—Decreased appetite—Glyburide—type 2 diabetes mellitus	0.00103	0.00217	CcSEcCtD
Pralatrexate—Asthenia—Sitagliptin—type 2 diabetes mellitus	0.00102	0.00216	CcSEcCtD
Pralatrexate—Folic Acid—CYP2E1—type 2 diabetes mellitus	0.00102	0.0657	CrCbGaD
Pralatrexate—Abdominal pain—Bromocriptine—type 2 diabetes mellitus	0.00102	0.00216	CcSEcCtD
Pralatrexate—Body temperature increased—Bromocriptine—type 2 diabetes mellitus	0.00102	0.00216	CcSEcCtD
Pralatrexate—Pruritus—Glimepiride—type 2 diabetes mellitus	0.00101	0.00214	CcSEcCtD
Pralatrexate—Diarrhoea—Pioglitazone—type 2 diabetes mellitus	0.00101	0.00212	CcSEcCtD
Pralatrexate—Epistaxis—Ramipril—type 2 diabetes mellitus	0.000999	0.00211	CcSEcCtD
Pralatrexate—Methotrexate—ABCC2—type 2 diabetes mellitus	0.000997	0.0641	CrCbGaD
Pralatrexate—Diarrhoea—Glimepiride—type 2 diabetes mellitus	0.000979	0.00207	CcSEcCtD
Pralatrexate—Diarrhoea—Sitagliptin—type 2 diabetes mellitus	0.000976	0.00206	CcSEcCtD
Pralatrexate—Vomiting—Glipizide—type 2 diabetes mellitus	0.000975	0.00206	CcSEcCtD
Pralatrexate—Oedema—Valsartan—type 2 diabetes mellitus	0.000974	0.00206	CcSEcCtD
Pralatrexate—Rash—Glipizide—type 2 diabetes mellitus	0.000967	0.00204	CcSEcCtD
Pralatrexate—Dermatitis—Glipizide—type 2 diabetes mellitus	0.000966	0.00204	CcSEcCtD
Pralatrexate—Gastrointestinal pain—Glyburide—type 2 diabetes mellitus	0.000965	0.00204	CcSEcCtD
Pralatrexate—Oedema—Orlistat—type 2 diabetes mellitus	0.000962	0.00203	CcSEcCtD
Pralatrexate—Thrombocytopenia—Valsartan—type 2 diabetes mellitus	0.000954	0.00202	CcSEcCtD
Pralatrexate—Anaemia—Irbesartan—type 2 diabetes mellitus	0.000948	0.002	CcSEcCtD
Pralatrexate—Dyspnoea—Gliclazide—type 2 diabetes mellitus	0.000945	0.002	CcSEcCtD
Pralatrexate—Back pain—Losartan—type 2 diabetes mellitus	0.000934	0.00197	CcSEcCtD
Pralatrexate—Abdominal pain—Glyburide—type 2 diabetes mellitus	0.000933	0.00197	CcSEcCtD
Pralatrexate—Anorexia—Valsartan—type 2 diabetes mellitus	0.000928	0.00196	CcSEcCtD
Pralatrexate—Asthenia—Bromocriptine—type 2 diabetes mellitus	0.000927	0.00196	CcSEcCtD
Pralatrexate—Leukopenia—Irbesartan—type 2 diabetes mellitus	0.000918	0.00194	CcSEcCtD
Pralatrexate—Fatigue—Gliclazide—type 2 diabetes mellitus	0.000914	0.00193	CcSEcCtD
Pralatrexate—Nausea—Glipizide—type 2 diabetes mellitus	0.000911	0.00193	CcSEcCtD
Pralatrexate—Vomiting—Glimepiride—type 2 diabetes mellitus	0.00091	0.00192	CcSEcCtD
Pralatrexate—Vomiting—Sitagliptin—type 2 diabetes mellitus	0.000907	0.00192	CcSEcCtD
Pralatrexate—Constipation—Gliclazide—type 2 diabetes mellitus	0.000906	0.00192	CcSEcCtD
Pralatrexate—Rash—Glimepiride—type 2 diabetes mellitus	0.000903	0.00191	CcSEcCtD
Pralatrexate—Dermatitis—Glimepiride—type 2 diabetes mellitus	0.000902	0.00191	CcSEcCtD
Pralatrexate—Rash—Sitagliptin—type 2 diabetes mellitus	0.0009	0.0019	CcSEcCtD
Pralatrexate—Dermatitis—Sitagliptin—type 2 diabetes mellitus	0.000899	0.0019	CcSEcCtD
Pralatrexate—Cough—Irbesartan—type 2 diabetes mellitus	0.000895	0.00189	CcSEcCtD
Pralatrexate—Anaemia—Losartan—type 2 diabetes mellitus	0.000892	0.00189	CcSEcCtD
Pralatrexate—Oedema—Metformin—type 2 diabetes mellitus	0.000887	0.00187	CcSEcCtD
Pralatrexate—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	0.000884	0.00187	CcSEcCtD
Pralatrexate—Thrombocytopenia—Metformin—type 2 diabetes mellitus	0.000868	0.00184	CcSEcCtD
Pralatrexate—Dyspnoea—Valsartan—type 2 diabetes mellitus	0.000868	0.00183	CcSEcCtD
Pralatrexate—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	0.000867	0.00183	CcSEcCtD
Pralatrexate—Leukopenia—Losartan—type 2 diabetes mellitus	0.000864	0.00183	CcSEcCtD
Pralatrexate—Nausea—Glimepiride—type 2 diabetes mellitus	0.00085	0.0018	CcSEcCtD
Pralatrexate—Nausea—Sitagliptin—type 2 diabetes mellitus	0.000848	0.00179	CcSEcCtD
Pralatrexate—Asthenia—Glyburide—type 2 diabetes mellitus	0.000847	0.00179	CcSEcCtD
Pralatrexate—Decreased appetite—Valsartan—type 2 diabetes mellitus	0.000847	0.00179	CcSEcCtD
Pralatrexate—Anorexia—Metformin—type 2 diabetes mellitus	0.000845	0.00179	CcSEcCtD
Pralatrexate—Cough—Losartan—type 2 diabetes mellitus	0.000842	0.00178	CcSEcCtD
Pralatrexate—Fatigue—Valsartan—type 2 diabetes mellitus	0.00084	0.00177	CcSEcCtD
Pralatrexate—Body temperature increased—Gliclazide—type 2 diabetes mellitus	0.000838	0.00177	CcSEcCtD
Pralatrexate—Abdominal pain—Gliclazide—type 2 diabetes mellitus	0.000838	0.00177	CcSEcCtD
Pralatrexate—Oedema—Irbesartan—type 2 diabetes mellitus	0.000837	0.00177	CcSEcCtD
Pralatrexate—Decreased appetite—Orlistat—type 2 diabetes mellitus	0.000837	0.00177	CcSEcCtD
Pralatrexate—Pruritus—Glyburide—type 2 diabetes mellitus	0.000835	0.00177	CcSEcCtD
Pralatrexate—Constipation—Valsartan—type 2 diabetes mellitus	0.000833	0.00176	CcSEcCtD
Pralatrexate—Fatigue—Orlistat—type 2 diabetes mellitus	0.00083	0.00175	CcSEcCtD
Pralatrexate—Vomiting—Bromocriptine—type 2 diabetes mellitus	0.000821	0.00174	CcSEcCtD
Pralatrexate—Thrombocytopenia—Irbesartan—type 2 diabetes mellitus	0.000819	0.00173	CcSEcCtD
Pralatrexate—Tachycardia—Irbesartan—type 2 diabetes mellitus	0.000817	0.00173	CcSEcCtD
Pralatrexate—Rash—Bromocriptine—type 2 diabetes mellitus	0.000814	0.00172	CcSEcCtD
Pralatrexate—Dermatitis—Bromocriptine—type 2 diabetes mellitus	0.000813	0.00172	CcSEcCtD
Pralatrexate—Diarrhoea—Glyburide—type 2 diabetes mellitus	0.000808	0.00171	CcSEcCtD
Pralatrexate—Anorexia—Irbesartan—type 2 diabetes mellitus	0.000798	0.00169	CcSEcCtD
Pralatrexate—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	0.000796	0.00168	CcSEcCtD
Pralatrexate—Dyspnoea—Metformin—type 2 diabetes mellitus	0.000791	0.00167	CcSEcCtD
Pralatrexate—Oedema—Losartan—type 2 diabetes mellitus	0.000788	0.00166	CcSEcCtD
Pralatrexate—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	0.000787	0.00166	CcSEcCtD
Pralatrexate—Thrombocytopenia—Losartan—type 2 diabetes mellitus	0.000771	0.00163	CcSEcCtD
Pralatrexate—Decreased appetite—Metformin—type 2 diabetes mellitus	0.000771	0.00163	CcSEcCtD
Pralatrexate—Abdominal pain—Valsartan—type 2 diabetes mellitus	0.00077	0.00163	CcSEcCtD
Pralatrexate—Tachycardia—Losartan—type 2 diabetes mellitus	0.000769	0.00162	CcSEcCtD
Pralatrexate—Nausea—Bromocriptine—type 2 diabetes mellitus	0.000767	0.00162	CcSEcCtD
Pralatrexate—Fatigue—Metformin—type 2 diabetes mellitus	0.000765	0.00162	CcSEcCtD
Pralatrexate—Abdominal pain—Orlistat—type 2 diabetes mellitus	0.000761	0.00161	CcSEcCtD
Pralatrexate—Body temperature increased—Orlistat—type 2 diabetes mellitus	0.000761	0.00161	CcSEcCtD
Pralatrexate—Asthenia—Gliclazide—type 2 diabetes mellitus	0.000761	0.00161	CcSEcCtD
Pralatrexate—Constipation—Metformin—type 2 diabetes mellitus	0.000758	0.0016	CcSEcCtD
Pralatrexate—Anorexia—Losartan—type 2 diabetes mellitus	0.000751	0.00159	CcSEcCtD
Pralatrexate—Vomiting—Glyburide—type 2 diabetes mellitus	0.000751	0.00159	CcSEcCtD
Pralatrexate—Pruritus—Gliclazide—type 2 diabetes mellitus	0.00075	0.00158	CcSEcCtD
Pralatrexate—Dyspnoea—Irbesartan—type 2 diabetes mellitus	0.000746	0.00158	CcSEcCtD
Pralatrexate—Rash—Glyburide—type 2 diabetes mellitus	0.000744	0.00157	CcSEcCtD
Pralatrexate—Dermatitis—Glyburide—type 2 diabetes mellitus	0.000744	0.00157	CcSEcCtD
Pralatrexate—Leukopenia—Ramipril—type 2 diabetes mellitus	0.000741	0.00157	CcSEcCtD
Pralatrexate—Decreased appetite—Irbesartan—type 2 diabetes mellitus	0.000728	0.00154	CcSEcCtD
Pralatrexate—Diarrhoea—Gliclazide—type 2 diabetes mellitus	0.000725	0.00153	CcSEcCtD
Pralatrexate—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	0.000725	0.00153	CcSEcCtD
Pralatrexate—Cough—Ramipril—type 2 diabetes mellitus	0.000722	0.00153	CcSEcCtD
Pralatrexate—Fatigue—Irbesartan—type 2 diabetes mellitus	0.000722	0.00152	CcSEcCtD
Pralatrexate—Constipation—Irbesartan—type 2 diabetes mellitus	0.000716	0.00151	CcSEcCtD
Pralatrexate—Dyspnoea—Losartan—type 2 diabetes mellitus	0.000702	0.00148	CcSEcCtD
Pralatrexate—Nausea—Glyburide—type 2 diabetes mellitus	0.000701	0.00148	CcSEcCtD
Pralatrexate—Abdominal pain—Metformin—type 2 diabetes mellitus	0.000701	0.00148	CcSEcCtD
Pralatrexate—Asthenia—Valsartan—type 2 diabetes mellitus	0.000699	0.00148	CcSEcCtD
Pralatrexate—Asthenia—Orlistat—type 2 diabetes mellitus	0.00069	0.00146	CcSEcCtD
Pralatrexate—Pruritus—Valsartan—type 2 diabetes mellitus	0.000689	0.00146	CcSEcCtD
Pralatrexate—Decreased appetite—Losartan—type 2 diabetes mellitus	0.000685	0.00145	CcSEcCtD
Pralatrexate—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	0.000684	0.00145	CcSEcCtD
Pralatrexate—Pruritus—Orlistat—type 2 diabetes mellitus	0.000681	0.00144	CcSEcCtD
Pralatrexate—Fatigue—Losartan—type 2 diabetes mellitus	0.000679	0.00144	CcSEcCtD
Pralatrexate—Oedema—Ramipril—type 2 diabetes mellitus	0.000675	0.00143	CcSEcCtD
Pralatrexate—Vomiting—Gliclazide—type 2 diabetes mellitus	0.000674	0.00142	CcSEcCtD
Pralatrexate—Constipation—Losartan—type 2 diabetes mellitus	0.000674	0.00142	CcSEcCtD
Pralatrexate—Rash—Gliclazide—type 2 diabetes mellitus	0.000668	0.00141	CcSEcCtD
Pralatrexate—Dermatitis—Gliclazide—type 2 diabetes mellitus	0.000668	0.00141	CcSEcCtD
Pralatrexate—Diarrhoea—Valsartan—type 2 diabetes mellitus	0.000666	0.00141	CcSEcCtD
Pralatrexate—Abdominal pain—Irbesartan—type 2 diabetes mellitus	0.000662	0.0014	CcSEcCtD
Pralatrexate—Body temperature increased—Irbesartan—type 2 diabetes mellitus	0.000662	0.0014	CcSEcCtD
Pralatrexate—Thrombocytopenia—Ramipril—type 2 diabetes mellitus	0.000661	0.0014	CcSEcCtD
Pralatrexate—Tachycardia—Ramipril—type 2 diabetes mellitus	0.000659	0.00139	CcSEcCtD
Pralatrexate—Diarrhoea—Orlistat—type 2 diabetes mellitus	0.000658	0.00139	CcSEcCtD
Pralatrexate—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	0.000644	0.00136	CcSEcCtD
Pralatrexate—Anorexia—Ramipril—type 2 diabetes mellitus	0.000644	0.00136	CcSEcCtD
Pralatrexate—Asthenia—Metformin—type 2 diabetes mellitus	0.000636	0.00134	CcSEcCtD
Pralatrexate—Nausea—Gliclazide—type 2 diabetes mellitus	0.00063	0.00133	CcSEcCtD
Pralatrexate—Pruritus—Metformin—type 2 diabetes mellitus	0.000627	0.00133	CcSEcCtD
Pralatrexate—Abdominal pain—Losartan—type 2 diabetes mellitus	0.000623	0.00132	CcSEcCtD
Pralatrexate—Body temperature increased—Losartan—type 2 diabetes mellitus	0.000623	0.00132	CcSEcCtD
Pralatrexate—Vomiting—Valsartan—type 2 diabetes mellitus	0.000619	0.00131	CcSEcCtD
Pralatrexate—Rash—Valsartan—type 2 diabetes mellitus	0.000614	0.0013	CcSEcCtD
Pralatrexate—Dermatitis—Valsartan—type 2 diabetes mellitus	0.000614	0.0013	CcSEcCtD
Pralatrexate—Vomiting—Orlistat—type 2 diabetes mellitus	0.000612	0.00129	CcSEcCtD
Pralatrexate—Diarrhoea—Metformin—type 2 diabetes mellitus	0.000607	0.00128	CcSEcCtD
Pralatrexate—Rash—Orlistat—type 2 diabetes mellitus	0.000607	0.00128	CcSEcCtD
Pralatrexate—Dermatitis—Orlistat—type 2 diabetes mellitus	0.000606	0.00128	CcSEcCtD
Pralatrexate—Dyspnoea—Ramipril—type 2 diabetes mellitus	0.000602	0.00127	CcSEcCtD
Pralatrexate—Asthenia—Irbesartan—type 2 diabetes mellitus	0.000601	0.00127	CcSEcCtD
Pralatrexate—Pruritus—Irbesartan—type 2 diabetes mellitus	0.000592	0.00125	CcSEcCtD
Pralatrexate—Decreased appetite—Ramipril—type 2 diabetes mellitus	0.000587	0.00124	CcSEcCtD
Pralatrexate—Fatigue—Ramipril—type 2 diabetes mellitus	0.000582	0.00123	CcSEcCtD
Pralatrexate—Nausea—Valsartan—type 2 diabetes mellitus	0.000578	0.00122	CcSEcCtD
Pralatrexate—Constipation—Ramipril—type 2 diabetes mellitus	0.000578	0.00122	CcSEcCtD
Pralatrexate—Diarrhoea—Irbesartan—type 2 diabetes mellitus	0.000573	0.00121	CcSEcCtD
Pralatrexate—Nausea—Orlistat—type 2 diabetes mellitus	0.000572	0.00121	CcSEcCtD
Pralatrexate—Asthenia—Losartan—type 2 diabetes mellitus	0.000565	0.00119	CcSEcCtD
Pralatrexate—Vomiting—Metformin—type 2 diabetes mellitus	0.000564	0.00119	CcSEcCtD
Pralatrexate—Rash—Metformin—type 2 diabetes mellitus	0.000559	0.00118	CcSEcCtD
Pralatrexate—Dermatitis—Metformin—type 2 diabetes mellitus	0.000559	0.00118	CcSEcCtD
Pralatrexate—Pruritus—Losartan—type 2 diabetes mellitus	0.000557	0.00118	CcSEcCtD
Pralatrexate—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	0.000552	0.00117	CcSEcCtD
Pralatrexate—Diarrhoea—Losartan—type 2 diabetes mellitus	0.000539	0.00114	CcSEcCtD
Pralatrexate—Abdominal pain—Ramipril—type 2 diabetes mellitus	0.000534	0.00113	CcSEcCtD
Pralatrexate—Body temperature increased—Ramipril—type 2 diabetes mellitus	0.000534	0.00113	CcSEcCtD
Pralatrexate—Vomiting—Irbesartan—type 2 diabetes mellitus	0.000532	0.00112	CcSEcCtD
Pralatrexate—Rash—Irbesartan—type 2 diabetes mellitus	0.000528	0.00112	CcSEcCtD
Pralatrexate—Dermatitis—Irbesartan—type 2 diabetes mellitus	0.000527	0.00111	CcSEcCtD
Pralatrexate—Nausea—Metformin—type 2 diabetes mellitus	0.000527	0.00111	CcSEcCtD
Pralatrexate—Vomiting—Losartan—type 2 diabetes mellitus	0.000501	0.00106	CcSEcCtD
Pralatrexate—Nausea—Irbesartan—type 2 diabetes mellitus	0.000497	0.00105	CcSEcCtD
Pralatrexate—Rash—Losartan—type 2 diabetes mellitus	0.000497	0.00105	CcSEcCtD
Pralatrexate—Dermatitis—Losartan—type 2 diabetes mellitus	0.000496	0.00105	CcSEcCtD
Pralatrexate—Asthenia—Ramipril—type 2 diabetes mellitus	0.000485	0.00102	CcSEcCtD
Pralatrexate—Pruritus—Ramipril—type 2 diabetes mellitus	0.000478	0.00101	CcSEcCtD
Pralatrexate—Nausea—Losartan—type 2 diabetes mellitus	0.000468	0.000989	CcSEcCtD
Pralatrexate—Diarrhoea—Ramipril—type 2 diabetes mellitus	0.000462	0.000977	CcSEcCtD
Pralatrexate—Vomiting—Ramipril—type 2 diabetes mellitus	0.000429	0.000908	CcSEcCtD
Pralatrexate—Rash—Ramipril—type 2 diabetes mellitus	0.000426	0.0009	CcSEcCtD
Pralatrexate—Dermatitis—Ramipril—type 2 diabetes mellitus	0.000425	0.000899	CcSEcCtD
Pralatrexate—Nausea—Ramipril—type 2 diabetes mellitus	0.000401	0.000848	CcSEcCtD
Pralatrexate—Methotrexate—ALB—type 2 diabetes mellitus	0.000384	0.0247	CrCbGaD
Pralatrexate—DHFR—Metabolism—NCOA6—type 2 diabetes mellitus	0.000164	0.000393	CbGpPWpGaD
Pralatrexate—DHFR—Disease—GCKR—type 2 diabetes mellitus	0.000164	0.000392	CbGpPWpGaD
Pralatrexate—FPGS—Disease—HIF1A—type 2 diabetes mellitus	0.000163	0.000391	CbGpPWpGaD
Pralatrexate—FPGS—Disease—IRS2—type 2 diabetes mellitus	0.000163	0.00039	CbGpPWpGaD
Pralatrexate—DHFR—Cell Cycle, Mitotic—PPP2CA—type 2 diabetes mellitus	0.000162	0.000389	CbGpPWpGaD
Pralatrexate—TYMS—Cell Cycle, Mitotic—CDKN2B—type 2 diabetes mellitus	0.000162	0.000388	CbGpPWpGaD
Pralatrexate—FPGS—Metabolism—GSTM1—type 2 diabetes mellitus	0.000162	0.000388	CbGpPWpGaD
Pralatrexate—TYMS—Cell Cycle—CCND2—type 2 diabetes mellitus	0.000162	0.000387	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—UCP2—type 2 diabetes mellitus	0.000161	0.000386	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—UCP3—type 2 diabetes mellitus	0.000161	0.000386	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—HSD11B1—type 2 diabetes mellitus	0.000161	0.000386	CbGpPWpGaD
Pralatrexate—SLC19A1—Metabolism—AGT—type 2 diabetes mellitus	0.00016	0.000383	CbGpPWpGaD
Pralatrexate—SLC19A1—Disease—INS—type 2 diabetes mellitus	0.00016	0.000383	CbGpPWpGaD
Pralatrexate—FPGS—Disease—CALM1—type 2 diabetes mellitus	0.00016	0.000383	CbGpPWpGaD
Pralatrexate—FPGS—Disease—APOE—type 2 diabetes mellitus	0.000159	0.000381	CbGpPWpGaD
Pralatrexate—FPGS—Metabolism—LPL—type 2 diabetes mellitus	0.000159	0.000381	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—STAR—type 2 diabetes mellitus	0.000158	0.000378	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—ACACA—type 2 diabetes mellitus	0.000158	0.000378	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—HSD17B3—type 2 diabetes mellitus	0.000158	0.000378	CbGpPWpGaD
Pralatrexate—FPGS—Disease—APOA1—type 2 diabetes mellitus	0.000157	0.000377	CbGpPWpGaD
Pralatrexate—SLC19A1—Metabolism—CALM1—type 2 diabetes mellitus	0.000157	0.000377	CbGpPWpGaD
Pralatrexate—DHFR—Disease—ALDOB—type 2 diabetes mellitus	0.000157	0.000376	CbGpPWpGaD
Pralatrexate—SLC19A1—Metabolism—APOE—type 2 diabetes mellitus	0.000157	0.000376	CbGpPWpGaD
Pralatrexate—FPGS—Metabolism—ADCY5—type 2 diabetes mellitus	0.000156	0.000373	CbGpPWpGaD
Pralatrexate—TYMS—Integrated Pancreatic Cancer Pathway—NFKB1—type 2 diabetes mellitus	0.000155	0.000372	CbGpPWpGaD
Pralatrexate—FPGS—Metabolism—GPX1—type 2 diabetes mellitus	0.000155	0.000372	CbGpPWpGaD
Pralatrexate—SLC19A1—Metabolism—APOA1—type 2 diabetes mellitus	0.000155	0.000371	CbGpPWpGaD
Pralatrexate—SLC19A1—Disease—AKT2—type 2 diabetes mellitus	0.000154	0.00037	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—PCK1—type 2 diabetes mellitus	0.000151	0.000363	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—ABCC8—type 2 diabetes mellitus	0.000151	0.000362	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—CBS—type 2 diabetes mellitus	0.000151	0.000362	CbGpPWpGaD
Pralatrexate—FPGS—Metabolism—CD36—type 2 diabetes mellitus	0.000151	0.000362	CbGpPWpGaD
Pralatrexate—DHFR—Disease—SPRY2—type 2 diabetes mellitus	0.00015	0.000358	CbGpPWpGaD
Pralatrexate—FPGS—Metabolism—PPP2CA—type 2 diabetes mellitus	0.000149	0.000357	CbGpPWpGaD
Pralatrexate—FPGS—Disease—NOS2—type 2 diabetes mellitus	0.000148	0.000355	CbGpPWpGaD
Pralatrexate—SLC19A1—Disease—SERPINE1—type 2 diabetes mellitus	0.000147	0.000352	CbGpPWpGaD
Pralatrexate—DHFR—Disease—RBP4—type 2 diabetes mellitus	0.000146	0.000349	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—SLC5A2—type 2 diabetes mellitus	0.000146	0.000349	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—COX2—type 2 diabetes mellitus	0.000146	0.000349	CbGpPWpGaD
Pralatrexate—DHFR—Cell Cycle—PPP2CA—type 2 diabetes mellitus	0.000145	0.000348	CbGpPWpGaD
Pralatrexate—TYMS—Cell Cycle—CDKN2B—type 2 diabetes mellitus	0.000145	0.000347	CbGpPWpGaD
Pralatrexate—TYMS—Integrated Pancreatic Cancer Pathway—SRC—type 2 diabetes mellitus	0.000145	0.000347	CbGpPWpGaD
Pralatrexate—FPGS—Metabolism—MTHFR—type 2 diabetes mellitus	0.000143	0.000343	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—NCOA6—type 2 diabetes mellitus	0.000143	0.000343	CbGpPWpGaD
Pralatrexate—FPGS—Disease—IRS1—type 2 diabetes mellitus	0.000142	0.00034	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—HK1—type 2 diabetes mellitus	0.000142	0.00034	CbGpPWpGaD
Pralatrexate—TYMS—Cell Cycle, Mitotic—PPP2CA—type 2 diabetes mellitus	0.000141	0.000339	CbGpPWpGaD
Pralatrexate—TYMS—Integrated Pancreatic Cancer Pathway—VEGFA—type 2 diabetes mellitus	0.000141	0.000338	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—HSD11B1—type 2 diabetes mellitus	0.000141	0.000337	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—UCP3—type 2 diabetes mellitus	0.000141	0.000337	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—UCP2—type 2 diabetes mellitus	0.000141	0.000337	CbGpPWpGaD
Pralatrexate—FPGS—Metabolism—PPARA—type 2 diabetes mellitus	0.00014	0.000336	CbGpPWpGaD
Pralatrexate—SLC19A1—Disease—PIK3R1—type 2 diabetes mellitus	0.00014	0.000336	CbGpPWpGaD
Pralatrexate—SLC19A1—Disease—NOS3—type 2 diabetes mellitus	0.00014	0.000336	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—KCNJ11—type 2 diabetes mellitus	0.000137	0.000328	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—GCKR—type 2 diabetes mellitus	0.000137	0.000328	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—HSD3B2—type 2 diabetes mellitus	0.000137	0.000328	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—LPA—type 2 diabetes mellitus	0.000137	0.000328	CbGpPWpGaD
Pralatrexate—DHFR—Cell Cycle, Mitotic—PRKCB—type 2 diabetes mellitus	0.000137	0.000327	CbGpPWpGaD
Pralatrexate—SLC19A1—Metabolism—PPARG—type 2 diabetes mellitus	0.000136	0.000327	CbGpPWpGaD
Pralatrexate—DHFR—Disease—SLC2A2—type 2 diabetes mellitus	0.000136	0.000326	CbGpPWpGaD
Pralatrexate—FPGS—Metabolism—AGT—type 2 diabetes mellitus	0.000136	0.000326	CbGpPWpGaD
Pralatrexate—FPGS—Disease—INS—type 2 diabetes mellitus	0.000136	0.000326	CbGpPWpGaD
Pralatrexate—SLC19A1—Metabolism—INS—type 2 diabetes mellitus	0.000134	0.000321	CbGpPWpGaD
Pralatrexate—FPGS—Metabolism—CALM1—type 2 diabetes mellitus	0.000134	0.00032	CbGpPWpGaD
Pralatrexate—DHFR—Disease—MTR—type 2 diabetes mellitus	0.000133	0.00032	CbGpPWpGaD
Pralatrexate—FPGS—Metabolism—APOE—type 2 diabetes mellitus	0.000133	0.000319	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—PCK1—type 2 diabetes mellitus	0.000132	0.000317	CbGpPWpGaD
Pralatrexate—FPGS—Metabolism—APOA1—type 2 diabetes mellitus	0.000132	0.000316	CbGpPWpGaD
Pralatrexate—FPGS—Disease—AKT2—type 2 diabetes mellitus	0.000131	0.000315	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—ALDOB—type 2 diabetes mellitus	0.000131	0.000315	CbGpPWpGaD
Pralatrexate—DHFR—Disease—NAMPT—type 2 diabetes mellitus	0.000131	0.000313	CbGpPWpGaD
Pralatrexate—DHFR—Disease—GCK—type 2 diabetes mellitus	0.00013	0.000311	CbGpPWpGaD
Pralatrexate—TYMS—Integrated Pancreatic Cancer Pathway—TGFB1—type 2 diabetes mellitus	0.000129	0.00031	CbGpPWpGaD
Pralatrexate—DHFR—Disease—IAPP—type 2 diabetes mellitus	0.000129	0.000309	CbGpPWpGaD
Pralatrexate—SLC19A1—Disease—PTGS2—type 2 diabetes mellitus	0.000128	0.000307	CbGpPWpGaD
Pralatrexate—TYMS—Integrated Pancreatic Cancer Pathway—EGFR—type 2 diabetes mellitus	0.000127	0.000304	CbGpPWpGaD
Pralatrexate—DHFR—Disease—SLC9A1—type 2 diabetes mellitus	0.000127	0.000304	CbGpPWpGaD
Pralatrexate—TYMS—Cell Cycle—PPP2CA—type 2 diabetes mellitus	0.000127	0.000303	CbGpPWpGaD
Pralatrexate—FPGS—Disease—SERPINE1—type 2 diabetes mellitus	0.000125	0.000299	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—HK1—type 2 diabetes mellitus	0.000124	0.000297	CbGpPWpGaD
Pralatrexate—SLC19A1—Metabolism—ALB—type 2 diabetes mellitus	0.000123	0.000294	CbGpPWpGaD
Pralatrexate—DHFR—Cell Cycle—PRKCB—type 2 diabetes mellitus	0.000122	0.000293	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—GLP1R—type 2 diabetes mellitus	0.000122	0.000293	CbGpPWpGaD
Pralatrexate—TYMS—Integrated Pancreatic Cancer Pathway—TNF—type 2 diabetes mellitus	0.000121	0.00029	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—LPA—type 2 diabetes mellitus	0.000119	0.000286	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—GCKR—type 2 diabetes mellitus	0.000119	0.000286	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—KCNJ11—type 2 diabetes mellitus	0.000119	0.000286	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—HSD3B2—type 2 diabetes mellitus	0.000119	0.000286	CbGpPWpGaD
Pralatrexate—TYMS—Cell Cycle, Mitotic—PRKCB—type 2 diabetes mellitus	0.000119	0.000286	CbGpPWpGaD
Pralatrexate—FPGS—Disease—PIK3R1—type 2 diabetes mellitus	0.000119	0.000286	CbGpPWpGaD
Pralatrexate—FPGS—Disease—NOS3—type 2 diabetes mellitus	0.000119	0.000286	CbGpPWpGaD
Pralatrexate—DHFR—Disease—HMGA1—type 2 diabetes mellitus	0.000119	0.000285	CbGpPWpGaD
Pralatrexate—SLC19A1—Metabolism—PIK3R1—type 2 diabetes mellitus	0.000117	0.000281	CbGpPWpGaD
Pralatrexate—SLC19A1—Metabolism—NOS3—type 2 diabetes mellitus	0.000117	0.000281	CbGpPWpGaD
Pralatrexate—DHFR—Disease—SNAP25—type 2 diabetes mellitus	0.000117	0.000279	CbGpPWpGaD
Pralatrexate—DHFR—Disease—PSMD6—type 2 diabetes mellitus	0.000117	0.000279	CbGpPWpGaD
Pralatrexate—FPGS—Metabolism—PPARG—type 2 diabetes mellitus	0.000116	0.000278	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—ALDOB—type 2 diabetes mellitus	0.000115	0.000275	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—SLC2A2—type 2 diabetes mellitus	0.000114	0.000273	CbGpPWpGaD
Pralatrexate—FPGS—Metabolism—INS—type 2 diabetes mellitus	0.000114	0.000273	CbGpPWpGaD
Pralatrexate—DHFR—Disease—CYBA—type 2 diabetes mellitus	0.000113	0.00027	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—MTR—type 2 diabetes mellitus	0.000112	0.000268	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—CPT1A—type 2 diabetes mellitus	0.000112	0.000268	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—NAMPT—type 2 diabetes mellitus	0.000109	0.000262	CbGpPWpGaD
Pralatrexate—DHFR—Disease—CALCA—type 2 diabetes mellitus	0.000109	0.000262	CbGpPWpGaD
Pralatrexate—FPGS—Disease—PTGS2—type 2 diabetes mellitus	0.000109	0.000261	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—LIPC—type 2 diabetes mellitus	0.000109	0.000261	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—HBA1—type 2 diabetes mellitus	0.000109	0.000261	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—GCK—type 2 diabetes mellitus	0.000109	0.000261	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—CYP11A1—type 2 diabetes mellitus	0.000108	0.000259	CbGpPWpGaD
Pralatrexate—SLC19A1—Metabolism—PTGS2—type 2 diabetes mellitus	0.000107	0.000257	CbGpPWpGaD
Pralatrexate—TYMS—Cell Cycle—PRKCB—type 2 diabetes mellitus	0.000107	0.000255	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—GLP1R—type 2 diabetes mellitus	0.000106	0.000255	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—SLC9A1—type 2 diabetes mellitus	0.000106	0.000255	CbGpPWpGaD
Pralatrexate—DHFR—Cell Cycle, Mitotic—CDKN2A—type 2 diabetes mellitus	0.000106	0.000254	CbGpPWpGaD
Pralatrexate—DHFR—Disease—SLC2A1—type 2 diabetes mellitus	0.000105	0.000253	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—CETP—type 2 diabetes mellitus	0.000105	0.000252	CbGpPWpGaD
Pralatrexate—FPGS—Metabolism—ALB—type 2 diabetes mellitus	0.000104	0.00025	CbGpPWpGaD
Pralatrexate—DHFR—Disease—NOS1—type 2 diabetes mellitus	0.000104	0.000249	CbGpPWpGaD
Pralatrexate—SLC19A1—Disease—SRC—type 2 diabetes mellitus	0.000104	0.000248	CbGpPWpGaD
Pralatrexate—DHFR—Disease—TCF7L2—type 2 diabetes mellitus	0.000103	0.000246	CbGpPWpGaD
Pralatrexate—DHFR—Disease—SLC2A4—type 2 diabetes mellitus	0.000101	0.000242	CbGpPWpGaD
Pralatrexate—FPGS—Metabolism—PIK3R1—type 2 diabetes mellitus	9.98e-05	0.000239	CbGpPWpGaD
Pralatrexate—FPGS—Metabolism—NOS3—type 2 diabetes mellitus	9.98e-05	0.000239	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—SLC2A2—type 2 diabetes mellitus	9.94e-05	0.000238	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—SNAP25—type 2 diabetes mellitus	9.76e-05	0.000234	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—SREBF1—type 2 diabetes mellitus	9.76e-05	0.000234	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—PSMD6—type 2 diabetes mellitus	9.76e-05	0.000234	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—CPT1A—type 2 diabetes mellitus	9.74e-05	0.000233	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—MTR—type 2 diabetes mellitus	9.74e-05	0.000233	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—CTGF—type 2 diabetes mellitus	9.58e-05	0.00023	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—NAMPT—type 2 diabetes mellitus	9.55e-05	0.000229	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—LIPC—type 2 diabetes mellitus	9.49e-05	0.000228	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—HBA1—type 2 diabetes mellitus	9.49e-05	0.000228	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—GCK—type 2 diabetes mellitus	9.49e-05	0.000228	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—HMGCR—type 2 diabetes mellitus	9.49e-05	0.000228	CbGpPWpGaD
Pralatrexate—DHFR—Cell Cycle—CDKN2A—type 2 diabetes mellitus	9.49e-05	0.000228	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—CYP11A1—type 2 diabetes mellitus	9.43e-05	0.000226	CbGpPWpGaD
Pralatrexate—TYMS—Circadian rythm related genes—IL6—type 2 diabetes mellitus	9.36e-05	0.000224	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—ADRA2A—type 2 diabetes mellitus	9.29e-05	0.000223	CbGpPWpGaD
Pralatrexate—SLC19A1—Disease—TGFB1—type 2 diabetes mellitus	9.27e-05	0.000222	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—SLC9A1—type 2 diabetes mellitus	9.26e-05	0.000222	CbGpPWpGaD
Pralatrexate—TYMS—Cell Cycle, Mitotic—CDKN2A—type 2 diabetes mellitus	9.26e-05	0.000222	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—CETP—type 2 diabetes mellitus	9.16e-05	0.00022	CbGpPWpGaD
Pralatrexate—FPGS—Metabolism—PTGS2—type 2 diabetes mellitus	9.13e-05	0.000219	CbGpPWpGaD
Pralatrexate—SLC19A1—Disease—EGFR—type 2 diabetes mellitus	9.09e-05	0.000218	CbGpPWpGaD
Pralatrexate—TYMS—Integrated Pancreatic Cancer Pathway—AKT1—type 2 diabetes mellitus	8.99e-05	0.000216	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—CYP2E1—type 2 diabetes mellitus	8.92e-05	0.000214	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—SLC2A1—type 2 diabetes mellitus	8.82e-05	0.000212	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—CYP1A2—type 2 diabetes mellitus	8.82e-05	0.000212	CbGpPWpGaD
Pralatrexate—FPGS—Disease—SRC—type 2 diabetes mellitus	8.81e-05	0.000211	CbGpPWpGaD
Pralatrexate—DHFR—Disease—TGFBR2—type 2 diabetes mellitus	8.79e-05	0.000211	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—CYP3A4—type 2 diabetes mellitus	8.61e-05	0.000206	CbGpPWpGaD
Pralatrexate—DHFR—Disease—CDKN2B—type 2 diabetes mellitus	8.51e-05	0.000204	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—PSMD6—type 2 diabetes mellitus	8.51e-05	0.000204	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—SNAP25—type 2 diabetes mellitus	8.51e-05	0.000204	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—SREBF1—type 2 diabetes mellitus	8.51e-05	0.000204	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—SLC2A4—type 2 diabetes mellitus	8.46e-05	0.000203	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—GCG—type 2 diabetes mellitus	8.46e-05	0.000203	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—CTGF—type 2 diabetes mellitus	8.36e-05	0.0002	CbGpPWpGaD
Pralatrexate—DHFR—Disease—APOB—type 2 diabetes mellitus	8.3e-05	0.000199	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—HMGCR—type 2 diabetes mellitus	8.28e-05	0.000199	CbGpPWpGaD
Pralatrexate—TYMS—Cell Cycle—CDKN2A—type 2 diabetes mellitus	8.28e-05	0.000199	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—ADRA2A—type 2 diabetes mellitus	8.1e-05	0.000194	CbGpPWpGaD
Pralatrexate—DHFR—Disease—LPL—type 2 diabetes mellitus	7.93e-05	0.00019	CbGpPWpGaD
Pralatrexate—FPGS—Disease—TGFB1—type 2 diabetes mellitus	7.88e-05	0.000189	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—CYP2E1—type 2 diabetes mellitus	7.79e-05	0.000187	CbGpPWpGaD
Pralatrexate—DHFR—Disease—ADCY5—type 2 diabetes mellitus	7.76e-05	0.000186	CbGpPWpGaD
Pralatrexate—FPGS—Disease—EGFR—type 2 diabetes mellitus	7.73e-05	0.000185	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—CYP1A2—type 2 diabetes mellitus	7.7e-05	0.000185	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—SLC2A1—type 2 diabetes mellitus	7.7e-05	0.000185	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—CYP3A4—type 2 diabetes mellitus	7.51e-05	0.00018	CbGpPWpGaD
Pralatrexate—DHFR—Disease—PPP2CA—type 2 diabetes mellitus	7.44e-05	0.000178	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—SLC2A4—type 2 diabetes mellitus	7.38e-05	0.000177	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—GCG—type 2 diabetes mellitus	7.38e-05	0.000177	CbGpPWpGaD
Pralatrexate—DHFR—Disease—CCR5—type 2 diabetes mellitus	7.3e-05	0.000175	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—PPARGC1A—type 2 diabetes mellitus	7.29e-05	0.000175	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—GNB3—type 2 diabetes mellitus	7.29e-05	0.000175	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—HMOX1—type 2 diabetes mellitus	7.26e-05	0.000174	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—CAT—type 2 diabetes mellitus	7.16e-05	0.000172	CbGpPWpGaD
Pralatrexate—DHFR—Disease—MTHFR—type 2 diabetes mellitus	7.14e-05	0.000171	CbGpPWpGaD
Pralatrexate—SLC19A1—Disease—IL6—type 2 diabetes mellitus	6.98e-05	0.000167	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—APOB—type 2 diabetes mellitus	6.95e-05	0.000167	CbGpPWpGaD
Pralatrexate—DHFR—Disease—HIF1A—type 2 diabetes mellitus	6.81e-05	0.000163	CbGpPWpGaD
Pralatrexate—DHFR—Disease—IRS2—type 2 diabetes mellitus	6.79e-05	0.000163	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—GSTM1—type 2 diabetes mellitus	6.76e-05	0.000162	CbGpPWpGaD
Pralatrexate—DHFR—Disease—CALM1—type 2 diabetes mellitus	6.67e-05	0.00016	CbGpPWpGaD
Pralatrexate—DHFR—Disease—APOE—type 2 diabetes mellitus	6.64e-05	0.000159	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—LPL—type 2 diabetes mellitus	6.64e-05	0.000159	CbGpPWpGaD
Pralatrexate—DHFR—Disease—APOA1—type 2 diabetes mellitus	6.57e-05	0.000157	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—ADCY5—type 2 diabetes mellitus	6.5e-05	0.000156	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—GPX1—type 2 diabetes mellitus	6.48e-05	0.000155	CbGpPWpGaD
Pralatrexate—SLC19A1—Disease—AKT1—type 2 diabetes mellitus	6.44e-05	0.000154	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—PPARGC1A—type 2 diabetes mellitus	6.36e-05	0.000153	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—GNB3—type 2 diabetes mellitus	6.36e-05	0.000153	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—HMOX1—type 2 diabetes mellitus	6.33e-05	0.000152	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—CD36—type 2 diabetes mellitus	6.31e-05	0.000151	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—CAT—type 2 diabetes mellitus	6.25e-05	0.00015	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—PPP2CA—type 2 diabetes mellitus	6.23e-05	0.000149	CbGpPWpGaD
Pralatrexate—DHFR—Disease—NOS2—type 2 diabetes mellitus	6.19e-05	0.000148	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—APOB—type 2 diabetes mellitus	6.07e-05	0.000145	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—MTHFR—type 2 diabetes mellitus	5.98e-05	0.000143	CbGpPWpGaD
Pralatrexate—FPGS—Disease—IL6—type 2 diabetes mellitus	5.94e-05	0.000142	CbGpPWpGaD
Pralatrexate—DHFR—Disease—IRS1—type 2 diabetes mellitus	5.93e-05	0.000142	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—GSTM1—type 2 diabetes mellitus	5.9e-05	0.000141	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—PPARA—type 2 diabetes mellitus	5.86e-05	0.000141	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—LPL—type 2 diabetes mellitus	5.79e-05	0.000139	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—AGT—type 2 diabetes mellitus	5.68e-05	0.000136	CbGpPWpGaD
Pralatrexate—DHFR—Disease—INS—type 2 diabetes mellitus	5.68e-05	0.000136	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—ADCY5—type 2 diabetes mellitus	5.67e-05	0.000136	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—GPX1—type 2 diabetes mellitus	5.65e-05	0.000135	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—CALM1—type 2 diabetes mellitus	5.58e-05	0.000134	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—APOE—type 2 diabetes mellitus	5.56e-05	0.000133	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—CD36—type 2 diabetes mellitus	5.5e-05	0.000132	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—APOA1—type 2 diabetes mellitus	5.5e-05	0.000132	CbGpPWpGaD
Pralatrexate—DHFR—Disease—AKT2—type 2 diabetes mellitus	5.49e-05	0.000132	CbGpPWpGaD
Pralatrexate—FPGS—Disease—AKT1—type 2 diabetes mellitus	5.48e-05	0.000131	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—PPP2CA—type 2 diabetes mellitus	5.43e-05	0.00013	CbGpPWpGaD
Pralatrexate—SLC19A1—Metabolism—AKT1—type 2 diabetes mellitus	5.4e-05	0.000129	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—MTHFR—type 2 diabetes mellitus	5.22e-05	0.000125	CbGpPWpGaD
Pralatrexate—DHFR—Disease—SERPINE1—type 2 diabetes mellitus	5.21e-05	0.000125	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—PPARA—type 2 diabetes mellitus	5.12e-05	0.000123	CbGpPWpGaD
Pralatrexate—DHFR—Disease—NOS3—type 2 diabetes mellitus	4.98e-05	0.000119	CbGpPWpGaD
Pralatrexate—DHFR—Disease—PIK3R1—type 2 diabetes mellitus	4.98e-05	0.000119	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—AGT—type 2 diabetes mellitus	4.96e-05	0.000119	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—CALM1—type 2 diabetes mellitus	4.87e-05	0.000117	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—APOE—type 2 diabetes mellitus	4.86e-05	0.000116	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—PPARG—type 2 diabetes mellitus	4.85e-05	0.000116	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—APOA1—type 2 diabetes mellitus	4.8e-05	0.000115	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—INS—type 2 diabetes mellitus	4.75e-05	0.000114	CbGpPWpGaD
Pralatrexate—FPGS—Metabolism—AKT1—type 2 diabetes mellitus	4.59e-05	0.00011	CbGpPWpGaD
Pralatrexate—DHFR—Disease—PTGS2—type 2 diabetes mellitus	4.55e-05	0.000109	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—ALB—type 2 diabetes mellitus	4.36e-05	0.000104	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—PPARG—type 2 diabetes mellitus	4.23e-05	0.000101	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—PIK3R1—type 2 diabetes mellitus	4.17e-05	9.99e-05	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—NOS3—type 2 diabetes mellitus	4.17e-05	9.99e-05	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—INS—type 2 diabetes mellitus	4.15e-05	9.94e-05	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—PTGS2—type 2 diabetes mellitus	3.81e-05	9.14e-05	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—ALB—type 2 diabetes mellitus	3.8e-05	9.12e-05	CbGpPWpGaD
Pralatrexate—DHFR—Disease—SRC—type 2 diabetes mellitus	3.68e-05	8.83e-05	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—PIK3R1—type 2 diabetes mellitus	3.64e-05	8.72e-05	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—NOS3—type 2 diabetes mellitus	3.64e-05	8.72e-05	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—PTGS2—type 2 diabetes mellitus	3.33e-05	7.97e-05	CbGpPWpGaD
Pralatrexate—DHFR—Disease—TGFB1—type 2 diabetes mellitus	3.29e-05	7.89e-05	CbGpPWpGaD
Pralatrexate—DHFR—Disease—EGFR—type 2 diabetes mellitus	3.23e-05	7.74e-05	CbGpPWpGaD
Pralatrexate—DHFR—Disease—IL6—type 2 diabetes mellitus	2.48e-05	5.95e-05	CbGpPWpGaD
Pralatrexate—DHFR—Disease—AKT1—type 2 diabetes mellitus	2.29e-05	5.48e-05	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—AKT1—type 2 diabetes mellitus	1.92e-05	4.59e-05	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—AKT1—type 2 diabetes mellitus	1.67e-05	4.01e-05	CbGpPWpGaD
